Serum Calprotectin: A promising Biomarker for Inflammatory Bowel Disease [IBD]
Background: These days, inflammatory bowel disease [IBD] is growing more common. Its diagnosis relies on invasive techniques like colonoscopy and biopsy, and its activity is monitored by fecal calprotectin levels that have a low compliance rate, so there is a pressing need for a serum biomarker that...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Al-Azhar University, Faculty of Medicine (Damietta)
2022-01-01
|
Series: | International Journal of Medical Arts |
Subjects: | |
Online Access: | https://ijma.journals.ekb.eg/article_211793_e4bfeb412d1a63114e65101643929cf8.pdf |